마우스 모델 기술 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 기술별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Mice Model Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By End Users, By Region, By Competition, 2020-2030F
상품코드:1881503
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 183 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 마우스 모델 기술 시장은 2024년에 13억 5,000만 달러로 평가되었으며, 2030년까지 CAGR 10.3%로 성장하여 24억 3,000만 달러에 달할 것으로 예측됩니다.
마우스 모델 기술이란 생물의학 연구, 신약개발, 독성학 연구를 위한 *in vivo* 도구로서 유전자재조합 마우스 계통 또는 근친교배 마우스 계통의 개발, 생산, 응용을 포함합니다. 이 시장의 성장을 뒷받침하는 주요 요인으로는 제약 및 생명공학 분야의 R&D 투자 증가, 맞춤형 의료 접근법에 대한 수요 증가, CRISPR/Cas9와 같은 유전공학 기술의 지속적인 발전으로 보다 정밀한 질병 모델링이 가능해졌다는 점 등을 들 수 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
13억 5,000만 달러
시장 규모 : 2030년
24억 3,000만 달러
CAGR : 2025-2030년
10.3%
가장 빠르게 성장하는 부문
CRISPR 녹아웃
최대 시장
북미
주요 시장 촉진요인
전 세계적으로 만성질환의 유병률 증가는 마우스 모델 기술 시장의 성장을 촉진하는 주요 요인으로 작용하고 있습니다. 암, 당뇨병, 신경질환 등의 질환은 병태생리 규명, 치료 표적 발굴, 효과적인 치료법 개발을 위해 광범위한 연구가 필요합니다.
주요 시장 과제
세계 마우스 모델 기술 시장의 성장을 저해하는 가장 큰 문제는 연구에서의 동물 복지를 규제하는 엄격한 윤리적 고려와 규제 프레임워크입니다. 이러한 프레임워크는 마우스 모델 개발 및 활용에 관여하는 연구기관과 제약회사에 막대한 관리 부담과 운영 비용의 증가를 초래하고 있습니다.
주요 시장 동향
인간화 마우스 모델 개발의 증가는 인간의 생리적 기능과 질병을 보다 충실하게 모방할 수 있는 전임상 도구의 필요성에서 비롯된 중요한 추세입니다. 이러한 모델은 특히 종양학, 면역학, 감염학 분야에서 신약 개발 및 개발의 번역적 관련성을 높입니다.
The Global Mice Model Technologies Market, valued at USD 1.35 Billion in 2024, is projected to experience a CAGR of 10.3% to reach USD 2.43 Billion by 2030. Mice model technologies encompass the development, production, and application of genetically modified or inbred mouse strains as *in vivo* tools for biomedical research, drug discovery, and toxicology studies. Key drivers supporting this market's growth include increasing research and development investments within the pharmaceutical and biotechnology sectors, the rising demand for personalized medicine approaches, and continuous advancements in genetic engineering techniques such as CRISPR/Cas9, which enable more precise disease modeling.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 1.35 Billion
Market Size 2030
USD 2.43 Billion
CAGR 2025-2030
10.3%
Fastest Growing Segment
CRISPR Knockout
Largest Market
North America
Key Market Drivers
The escalating global prevalence of chronic diseases acts as a primary catalyst for growth within the mice model technologies market. Conditions such as cancer, diabetes, and neurological disorders necessitate extensive research to elucidate pathogenesis, identify therapeutic targets, and develop effective treatments. Mice models are indispensable tools, providing physiologically relevant *in vivo* systems for disease modeling and drug efficacy testing. The increased burden of these diseases drives demand for specialized mouse models that accurately recapitulate human disease phenotypes. For instance, according to the National Cancer Institute, in an article dated April 4, 2024, "Fiscal Year 2024 Appropriation - NCI", the total appropriation for NCI in fiscal year 2024 was $7.22 billion for cancer research, fueling the application of advanced mouse models crucial for oncology investigations.
Key Market Challenges
A significant challenge impeding the growth of the Global Mice Model Technologies Market is the stringent ethical considerations and regulatory frameworks governing animal welfare in research. These frameworks impose substantial administrative burdens and increased operational costs on research institutions and pharmaceutical companies involved in developing and utilizing mouse models. Navigating complex approval processes for animal studies can extend timelines for drug discovery and toxicology assessments, thereby slowing the development and application of new mouse models.
Key Market Trends
The increasing development of humanized mice models is a significant trend, driven by the need for preclinical tools that more closely mimic human physiology and disease. These models enhance the translational relevance of drug discovery and development, especially in oncology, immunology, and infectious diseases. Charles River Laboratories, in December 2023, highlighted advancements in next-generation humanized models through CRISPR-mediated genetic modification, expanding their utility for immuno-oncology research.
Key Market Players
Biocytogen LLC
Charles River Laboratories Inc.
Cyagen Biosciences
GemPharmatech Co Ltd.
genOway S.A.
Ingenious Targeting Laboratory Inc.
Merck KGaA.
Ozgene Pty Ltd.
Taconic Biosciences Inc.
Polygena AG
Report Scope:
In this report, the Global Mice Model Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Mice Model Technologies Market, By Technology:
CRISPR Knockout
Random Insertions
Large and Targeted Insertions
ES Cell Modification (Homologous Recombination)
Others
Mice Model Technologies Market, By End Users:
Pharmaceutical Companies
Biotechnology Companies
Academic and Research Facilities
Contract Research and Manufacturing Organizations
Mice Model Technologies Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Mice Model Technologies Market.
Available Customizations:
Global Mice Model Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Mice Model Technologies Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technology (CRISPR Knockout, Random Insertions, Large and Targeted Insertions, ES Cell Modification (Homologous Recombination), Others)
5.2.2. By End Users (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Facilities, Contract Research and Manufacturing Organizations)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Mice Model Technologies Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By End Users
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Mice Model Technologies Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technology
6.3.1.2.2. By End Users
6.3.2. Canada Mice Model Technologies Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technology
6.3.2.2.2. By End Users
6.3.3. Mexico Mice Model Technologies Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technology
6.3.3.2.2. By End Users
7. Europe Mice Model Technologies Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By End Users
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Mice Model Technologies Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By End Users
7.3.2. France Mice Model Technologies Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By End Users
7.3.3. United Kingdom Mice Model Technologies Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technology
7.3.3.2.2. By End Users
7.3.4. Italy Mice Model Technologies Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Technology
7.3.4.2.2. By End Users
7.3.5. Spain Mice Model Technologies Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Technology
7.3.5.2.2. By End Users
8. Asia Pacific Mice Model Technologies Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By End Users
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Mice Model Technologies Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By End Users
8.3.2. India Mice Model Technologies Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By End Users
8.3.3. Japan Mice Model Technologies Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By End Users
8.3.4. South Korea Mice Model Technologies Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Technology
8.3.4.2.2. By End Users
8.3.5. Australia Mice Model Technologies Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Technology
8.3.5.2.2. By End Users
9. Middle East & Africa Mice Model Technologies Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By End Users
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Mice Model Technologies Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By End Users
9.3.2. UAE Mice Model Technologies Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By End Users
9.3.3. South Africa Mice Model Technologies Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By End Users
10. South America Mice Model Technologies Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technology
10.2.2. By End Users
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Mice Model Technologies Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technology
10.3.1.2.2. By End Users
10.3.2. Colombia Mice Model Technologies Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technology
10.3.2.2.2. By End Users
10.3.3. Argentina Mice Model Technologies Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technology
10.3.3.2.2. By End Users
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Mice Model Technologies Market: SWOT Analysis
